DOCSLIB.ORG

Efficient Culture of Human Naive and Memory B Cells for Use As Apcs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Efficient Culture of Human Naive and Memory B Cells for Use As Apcs Efficient Culture of Human Naive and Memory B Cells for Use as APCs Kuei-Ying Su, Akiko Watanabe, Chen-Hao Yeh, Garnett Kelsoe and Masayuki Kuraoka This information is current as of September 25, 2021. J Immunol 2016; 197:4163-4176; Prepublished online 10 October 2016; doi: 10.4049/jimmunol.1502193 http://www.jimmunol.org/content/197/10/4163 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2016/10/07/jimmunol.150219 Material 3.DCSupplemental References This article cites 91 articles, 42 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/197/10/4163.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Efficient Culture of Human Naive and Memory B Cells for Use as APCs Kuei-Ying Su,*,†,1 Akiko Watanabe,*,1 Chen-Hao Yeh,* Garnett Kelsoe,*,‡ and Masayuki Kuraoka* The ability to culture and expand B cells in vitro has become a useful tool for studying human immunity. A limitation of current methods for human B cell culture is the capacity to support mature B cell proliferation. We developed a culture method to support the efficient activation and proliferation of naive and memory human B cells. This culture supports extensive B cell proliferation, with ∼103-fold increases following 8 d in culture and 106-fold increases when cultures are split and cultured for 8 more days. In culture, a significant fraction of naive B cells undergo isotype switching and differentiate into plasmacytes. Culture-derived (CD) B cells are readily cryopreserved and, when recovered, retain their ability to proliferate and differentiate. Significantly, prolif- erating CD B cells express high levels of MHC class II, CD80, and CD86. CD B cells act as APCs and present alloantigens and Downloaded from microbial Ags to T cells. We are able to activate and expand Ag-specific memory B cells; these cultured cells are highly effective in presenting Ag to T cells. We characterized the TCR repertoire of rare Ag-specific CD4+ T cells that proliferated in response to tetanus toxoid (TT) presented by autologous CD B cells. TCR Vb usage by TT-activated CD4+ T cells differs from resting and unspecifically activated CD4+ T cells. Moreover, we found that TT-specific TCR Vb usage by CD4+ T cells was substantially different between donors. This culture method provides a platform for studying the BCR and TCR repertoires within a single individual. The Journal of Immunology, 2016, 197: 4163–4176. http://www.jimmunol.org/ cells are key to adaptive immunity and are now rec- The Ag-presentation function of B cells has long been known ognized for their multifunctionality; B cells not only (9, 10), and B cells are recognized as professional APCs along B produce Abs, they also present Ags to T cells (1), se- with dendritic cells (DCs), macrophages, and thymic epithelial crete cytokines (2), and regulate other immunocytes (3). Ag cells (11). Ag-presenting B cells participate in the initiation and presentation by B cells is involved, to a significant extent, in continuation of autoimmune diseases, such as systemic lupus immunoprotection and the pathogenesis of autoimmune dis- erythematosus (12, 13), rheumatoid arthritis (14, 15), type 1 dia- eases (1, 4, 5). The effects of Ag presentation by B cells on betes (16), and multiple sclerosis (5), in humans and mice. Beyond by guest on September 25, 2021 T cells depend on the activation state of B cells. Studies show the scope of autoimmunity, B cells serving as APCs are charac- that CD154- or mitogen-activated B cells function as effective teristic of atherosclerosis (17), insulin resistance (18), allergy (19), APCs to induce T cell activation (6, 7), whereas resting B cells allorejection (20), infection, and even immune responses elicited are tolerogenic (8). by vaccination (21). On the whole, professional APCs initiate adaptive immune *Department of Immunology, Duke University, Durham, NC 27710; †Tzu Chi Med- cellular responses by processing and presenting Ags to T cells, as ical Center, Hualien 970, Taiwan; and ‡Human Vaccine Institute, Duke University, well as by providing costimulatory signals necessary for the ac- Durham, NC 27710 tivation of T cells. These functional properties of APCs were 1K.-Y.S. and A.W. contributed equally to this work. applied in the clinical assessment of T cell responses in vitro; for ORCIDs: 0000-0002-7927-2310 (K.-Y.S.); 0000-0003-4741-4705 (A.W.); 0000- example, to evaluate the efficacy of vaccination (22), to identify the 0001-5801-2918 (C.-H.Y.). causal allergens for patients (23), and to predict the compatibility Received for publication October 19, 2015. Accepted for publication August 30, of allografts (24). Generally, autologous APCs are loaded with 2016. target Ags and are cocultured with T cells; T cell proliferation or This work was supported in part by Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant AI100645-02 and Autoimmunity Center of Excel- function is then measured (25, 26). To develop effective vaccines lence Grant AI56363. that target T cells, epitope mapping of the vaccine Ags is inevi- The TCRb sequence data sets presented in this article have been submitted to the immu- table (22). This is because T cell responses are generally focused noSEQ Analyzer database (https://clients.adaptivebiotech.com/pub/9816555b-5673-4316- on only a few epitopes among the many present on microbial 85e2-244acb293f0b) under accession numbers 14_d0_CD4naive-2016881253, 14_d7_activatedCD4-2016881253, 14_d7_TTspecificCD4-2016881253, 6_d0_CD4naive- pathogens (27). With ample epitope candidates and multiple 2016881253, 6_d7_activatedCD4-2016881253, and 6_d7_TTspecificCD4-2016881253. rounds of screening, a thorough mapping of T cell epitopes re- Address correspondence and reprint requests to Prof. Garnett Kelsoe, Duke Univer- quires large numbers of APCs (22, 28, 29). sity Medical Center 3010, 117 Jones Building, Research Drive, Durham, NC 27710. Indeed, the availability of autologous APCs is often problematic in E-mail address: [email protected] studies of human T cell responses (22). Although tetramers of MHC The online version of this article contains supplemental material. molecules conjugated with peptides provides an alternative option for Abbreviations used in this article: 7-AAD, 7-aminoactinomycin D; CD, culture- derived; DC, dendritic cell; FSC, forward scatter; HA, recombinant influenza hem- measuring T cell responses to specific Ags (30), in practice, only limited agglutinin; MFI, mean fluorescent intensity; MHCII, MHC class II; rPA, recombinant numbers of Ags can be assessed using tetramers (31), restricting the Bacillus anthracis protective Ag; Td, tetanus–diphtheria toxoid; TT, tetanus toxoid; application of tetramers in large-scale evaluations of candidate epitopes. TT-PE, TT conjugated with PE. For this reason, autologous APCs are still the primary choice in T cell Copyright Ó 2016 by The American Association of Immunologists, Inc. 0022-1767/16/$30.00 epitope discovery. To overcome the low numbers of APCs in the www.jimmunol.org/cgi/doi/10.4049/jimmunol.1502193 4164 EFFICIENT CULTURE SYSTEM FOR HUMAN B CELLS circulating blood, usually the rate-limiting step for mapping PBS containing 2% FBS prior to analysis. Bound biotin-conjugated Abs human T cell epitopes, leukapheresis is often required to obtain were revealed by fluorochrome-labeled streptavidin. Doublets were ex- adequate numbers of APCs from a patient’s blood (28, 29). Alterna- cluded from our analysis and cell sorting by combination(s) of forward scatter (FSC)-A versus FSC-H, FSC-H versus FSC-W, and side scatter-H tively, APCs can be expanded in vitro. The low numbers of circulating versus side scatter-W gatings. Dead cells were excluded by positive DCs and macrophages in blood and their limited capacity for prolif- 7-aminoactinomycin D (7-AAD) staining (BD Biosciences). Labeled cells eration in vitro limit their applications (32–34). In contrast, B cells are were analyzed on a BD FACSCanto after fixation (BD Cytofix) or sorted on more abundant in circulating blood and are easier to expand in vitro a BD FACSAria using Diva software (BD Biosciences). compared with DCs and macrophages (35–37). To that end, B cells Isolation of mature naive B cells offer a useful and a potentially more convenient source of APCs; Human mature naive B cells were isolated from PBMCs by negative se- however, current methods for B cell culture still do not generate suf- lection with the EasySep Human Naive B Cell Enrichment Kit, according to ficient cell numbers (35–37). the manufacturer’s instructions (STEMCELL Technologies). The purity of In this study, we adapted the culture methods established by Luo mature naive B cells (CD19+CD272IgM+IgD+), as determined by flow et al. (38) to expand in vitro the numbers of naive and memory cytometry, was .94%. human B cells. This culture method efficiently induces the activa- CD culture system tion, proliferation, and differentiation of unselected or Ag-binding 3 3 B cells. Significantly, the culture-derived (CD) B cells express high Human B cells (1–6 10 ) were plated in six-well plates or 10-cm tissue culture dishes (BD Falcon) to achieve input cell densities of ∼100 B cells levels of accessory molecules necessary for effective APC function per cm2.
Load more

Recommended publications
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • Overview of B-Cell Maturation, Activation, Differentiation
    Overview of B-Cell Maturation, Activation, Differentiation B-Cell Development Begins in the Bone Marrow and Is Completed in the Periphery Antigen-Independent (Maturation) 1) Pro-B stages B-cell markers 2) Pre B-stages H- an L- chain loci rearrangements surrogate light chain 3) Naïve B-cell functional BCR . B cells are generated in the bone marrow. Takes 1-2 weeks to develop from hematopoietic stem (HSC) cells to mature B cells. Sequence of expression of cell surface receptor and adhesion molecules which allows for differentiation of B cells, proliferation at various stages, and movement within the bone marrow microenvironment. HSC passes through progressively more delimited progenitor-cell stages until it reaches the pro-B cell stage. Pre-B cell is irreversibly committed to the B-cell lineage and the recombination of the immunoglobulin genes expressed on the cell surface Immature B cell (transitional B cell) leaves the bone marrow to complete its maturation in the spleen through further differentiation. Immune system must create a repertoire of receptors capable of recognizing a large array of antigens while at the Source: Internet same time eliminating self-reactive B cells. B-Cell Activation and Differentiation • Exposure to antigen or various polyclonal mitogens activates resting B cells and stimulates their proliferation. • Activated B cells lose expression of sIgD and CD21 and acquire expression of activation antigens. Growth factor receptors, structures involved in cell-cell interaction, molecules that play a role in the localization and binding of activated B cells Two major types: T cell dependent (TD) T cell independent (TI) B-Cell Activation by Thymus-Independent and Dependent Antigens Source: Kuby T cell dependent: Involves protein antigens and CD4+ helper T cells.
    [Show full text]
  • B-Cell Reconstitution Recapitulates B-Cell Lymphopoiesis Following Haploidentical BM Transplantation and Post-Transplant CY
    Bone Marrow Transplantation (2015) 50, 317–319 © 2015 Macmillan Publishers Limited All rights reserved 0268-3369/15 www.nature.com/bmt LETTER TO THE EDITOR B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY Bone Marrow Transplantation (2015) 50, 317–319; doi:10.1038/ From week 9, the proportion of transitional B cells progressively bmt.2014.266; published online 24 November 2014 decreased (not shown), whereas that of mature B cells increased (Figure 1d). To further evaluate the differentiation of mature cells, we included markers of naivety (IgM and IgD) and memory (IgG) in The treatment of many hematological diseases benefits from our polychromatic panel. At week 9, when a sufficient proportion myeloablative or non-myeloablative conditioning regimens of cells were available for the analysis, B cells were mostly naive followed by SCT or BMT. HLA-matched donors are preferred but and remained so for 26 weeks after haploBMT (Figure 1d). Despite not always available. Instead, haploidentical donors can be rapidly low, the proportion of memory B cells reached levels similar to identified. Unmanipulated haploidentical BMT (haploBMT) with that of marrow donors (Supplementary Figure 1D). non-myeloablative conditioning and post-transplant Cy has been To further investigate the steps of B-cell maturation, we developed to provide a universal source of BM donors.1 Cy, analyzed CD5, a regulator of B-cell activation, and CD21, a which depletes proliferating/allogeneic cells, prevents GVHD.1 component of the B-cell coreceptor complex, on transitional B Importantly, the infection-related mortality was remarkably low, cells. These surface markers characterize different stages of 5,6 5,6 suggesting effective immune reconstitution.1,2 However, a transitional B-cell development.
    [Show full text]
  • Human B Cell Isolation Product Selection Diagram
    Human B Cell Isolation Product Selection Explore the infographic below to find the correct human B cell isolation product for your application. 1. Your Starting Sample Whole Peripheral Blood/Buffy Coat PBMCs/Leukapheresis Pack 2. Cell Separation Platform Immunodensity Cell Separation Immunomagnetic Cell Separation Immunomagnetic Cell Separation 3. Product Line RosetteSep™ EasySep™ EasySep™ Sequential Selection Negative Selection Negative Selection Positive Selection Negative Selection Positive Selection 4. Selection Method (Positive + Negative) iRosetteSep™ HLA iEasySep™ Direct HLA i, iiEasySep™ HLA iEasySep™ HLA B Cell viEasySep™ Human CD19 EasySep™ Human IgG+ B Cell Enrichment Cocktail B Cell Isolation Kit Chimerism Whole Blood Enrichment Kit Positive Selection Kit II Memory B Cell Isolation (15064HLA)1, 2, 3 (89684) / EasySep™ Direct B Cell Positive Selection (19054HLA)1, 2 (17854)1, 2 Kit (17868)1 (optional), 2' HLA Crossmatch B Cell Kit (17886)1, 2 Isolation Kit (19684 - 1, 2 RosetteSep™ Human available in the US only) iiiEasySep™ Human B Cell viEasySep™ Release EasySep™ Human Memory 5. Cell Isolation Kits B Cell Enrichment Cocktail i, iiEasySep™ HLA Enrichment Kit Human CD19 Positive B Cell Isolation Kit 1, 2, 3 1, 2 1, 2 1 (optional), 2 Catalog #s shown in ( ) (15024) Chimerism Whole Blood (19054) Selection Kit (17754) (17864) EasySep™ Direct Human CD19 Positive Selection B-CLL Cell Isolation Kit Kit (17874)1, 2 1, 2, 3, 4 *RosetteSep™ Human (19664) iiiEasySep™ Human B Cell EasySep™ Human CD138 Multiple Myeloma Cell Isolation Kit
    [Show full text]
  • 1 the Immune System
    1 The immune system The immune response Innate immunity Adaptive immunity The immune system comprises two arms (rapid response) (slow response) functioning cooperatively to provide a Dendritic cell Mast cell comprehensive protective response: the B cell innate and the adaptive immune system. Macrophage γδ T cell T cell The innate immune system is primitive, does not require the presentation of an antigen, Natural and does not lead to immunological memory. killer cell Basophil Its effector cells are neutrophils, Complement protein macrophages, and mast cells, reacting Antibodies Natural Eosinophil killer T cell CD4+ CD8+ within minutes to hours with the help of T cell T cell complement activation and cytokines (CK). Granulocytes Neutrophil B-lymphocytes B-cell receptor The adaptive immune response is provided by the lymphocytes, which precisely recognise unique antigens (Ag) through cell-surface receptors. epitope Receptors are obtained in billions of variations through antigen cut and splicing of genes and subsequent negative T-lymphocytes selection: self-recognising lymphocytes are eradicated. T-cell receptor Immunological memory after an Ag encounter permits a faster and heightened state of response on a subsequent exposure. epitope MHC Lymphocytes develop in primary lymphoid tissue (bone marrow [BM], thymus) and circulate towards secondary Tonsils and adenoids Lymph lymphoid tissue (lymph nodes [LN], spleen, MALT). nodes Lymphatic vessels The Ag reach the LN carried by lymphocytes or by Thymus dendritic cells. Lymphocytes enter the LN from blood Lymph transiting through specialised endothelial cells. nodes The Ag is processed within the LN by lymphocytes, Spleen macrophages, and other immune cells in order to mount a specific immune response.
    [Show full text]
  • Human Naive B Cells Cells by Cpg Oligodeoxynucleotide-Primed T+
    Presentation of Soluble Antigens to CD8+ T Cells by CpG Oligodeoxynucleotide-Primed Human Naive B Cells This information is current as Wei Jiang, Michael M. Lederman, Clifford V. Harding and of September 27, 2021. Scott F. Sieg J Immunol 2011; 186:2080-2086; Prepublished online 14 January 2011; doi: 10.4049/jimmunol.1001869 http://www.jimmunol.org/content/186/4/2080 Downloaded from References This article cites 36 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/186/4/2080.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Presentation of Soluble Antigens to CD8+ T Cells by CpG Oligodeoxynucleotide-Primed Human Naive B Cells Wei Jiang,*,† Michael M. Lederman,*,† Clifford V. Harding,†,‡ and Scott F. Sieg*,† Naive B lymphocytes are generally thought to be poor APCs, and there is limited knowledge of their role in activation of CD8+ T cells.
    [Show full text]
  • Plasma Cells: Finding New Light at the End of B Cell Development Kathryn L
    © 2001 Nature Publishing Group http://immunol.nature.com REVIEW Plasma cells: finding new light at the end of B cell development Kathryn L. Calame Plasma cells are cellular factories devoted entire- Upon plasma cell differentiation, there is a marked increase in ly to the manufacture and export of a single prod- steady-state amounts of Ig heavy and light chain mRNA and, when 2 uct: soluble immunoglobulin (Ig). As the final required for IgM and IgA secretion, J chain mRNA . Whether the increase in Ig mRNA is due to increased transcription, increased mediators of a humoral response, plasma cells mRNA stability or, as seems likely, both mechanisms, remains con- play a critical role in adaptive immunity.Although troversial2. There is also an increase in secreted versus membrane intense effort has been devoted to studying the forms of heavy chain mRNA, as determined by differential use of poly(A) sites that may involve the availability of one component of regulation and requirements for early B cell the polyadenylation machinery, cleavage-stimulation factor Cst-643. development, little information has been avail- To accommodate translation and secretion of the abundant Ig able on plasma cells. However, more recent mRNAs, plasma cells have an increased cytoplasmic to nuclear ratio work—including studies on genetically altered and prominent amounts of rough endoplasmic reticulum and secreto- ry vacuoles. mice and data from microarray analyses—has Numerous B cell–specific surface proteins are down-regulated begun to identify the regulatory cascades that upon plasma cell differentiation, including major histocompatibility initiate and maintain the plasma cell phenotype. complex (MHC) class II, B220, CD19, CD21 and CD22.
    [Show full text]
  • B Cell Responses: Plasmablasts Walk the Line
    RESEARCH HIGHLIGHTS B CELL RESPONSES Plasmablasts walk the line During an adaptive immune patterns in lymph nodes. Following molecule intercellular adhesion response, long-lived antibody- immunization with specific antigen, molecule 1 (ICAM1) in plasmablast producing plasma cells are generated YFP+ cells mainly aggregated in migration. Both YFP+ and naive in T cell-dependent germinal centres. the medulla of the lymph node but B cells migrated on ICAM1-coated Plasma cells subsequently localize to could also be found in the B and glass surfaces, but only naive B cells the lymph node medullary chords, T cell zones and at the border of required Gαi-signalling for this move- but their migration to these sites has germinal centres. By contrast, naive ment. In addition, naive B cells and never been directly observed. A study B cells were predominantly localized plasma blasts had different migratory in Immunity has now reported in B cell follicles. behaviour on the ICAM1-coated sur- unique migratory behaviour for their When the migratory patterns faces; naive B cells showed frequent precursors, plasmablasts; these cells of the different populations were detachment and reattachment to the traverse the lymph node in a linear observed in situ using time-lapse substrate, but YFP+ cells migrated in manner and, surprisingly, do not two-photon intravital microscopy, a steady, amoeboid manner. + require Gαi-coupled receptor YFP cells in the medullary chords Interestingly, in assays carried signalling to migrate. were found to be mainly stationary, out in vivo and in vitro, the authors The transcriptional repressor but YFP+ cells in the follicles were reported an inverse correlation B lymphocyte-induced maturation highly motile.
    [Show full text]
  • A Two-Step Non-Flowcytometry-Based Naïve B Cell Isolation Method and Its Application in Staphylococcal Enterotoxin B (SEB) Presentation
    Original article A two-step non-flowcytometry-based naïve B cell isolation method and its application in Staphylococcal enterotoxin B (SEB) presentation Kaj Chokeshai-u-saha,1 Supranee Buranapraditkun,1 Alain Jacquet,1 Catherine Nguyen 2,3 and Kiat Ruxrungtham 1 Summary Conclusions: This two-step non-flow cytometry- Background: To study the role of human naïve B based approach improved the purity of isolated cells in antigen presentation and stimulation to naïve B cells compared with conventional one- naïve CD4 +T cell, a suitable method to step magnetic bead method. It also worked well reproducibly isolate sufficient naïve B cells is with a small blood volume. In addition, this study required. showed that the isolated naïve B cells can present a super-antigen “SEB” to activate naïve CD4 Methods: To improve the purity of isolated naïve cells. These methods may thus be useful for B cells obtained from a conventional one-step further in vitro characterization of human naïve magnetic bead method, we added a rosetting step B cells and their roles as antigen presenting cells to enrich total B cell isolates from human whole in various diseases. (Asian Pac J Allergy Immunol blood samples prior to negative cell sorting by 2012;30:214-23) magnetic beads. The acquired naïve B cells were analyzed for phenotypes and for their role in Keywords: Naïve B cell, antigen presentation, naïve Staphylococcal enterotoxin B (SEB) presentation CD4 +T cell, resetting, magnetic cell sorting, to naïve CD4 +T cells. superantigen, staphylococcal enterotoxin B (SEB) Results: The mean (SD) naïve B cell Introduction (CD19+/CD27-) purity obtained from this two- Human naïve B cells are defined as mature B step method compared with the one-step method cells that have never been exposed to antigens.
    [Show full text]
  • Molecular Regulation of Peripheral B Cells and Their Progeny in Immunity
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Molecular regulation of peripheral B cells and their progeny in immunity Mark R. Boothby,1,2 Emily Hodges,3 and James W. Thomas1,2 1Department of Pathology–Microbiology–Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA; 2Department of Medicine, Rheumatology Division, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA; 3Department of Biochemistry, Vanderbilt Genetics Institute, Nashville, Tennessee 37232, USA Mature B lymphocytes are crucial components of adap- potentials. A vast trove of findings illuminates the tran- tive immunity, a system essential for the evolutionary fit- scriptional regulation and chromatin modifications (for ness of mammals. Adaptive lymphocyte function requires convenience, referred to here as epigenetic) that program an initially naïve cell to proliferate extensively and its developmental progression from common lymphoid pro- progeny to have the capacity to assume a variety of fates. genitors (CLPs) to the establishment of the naïve popu- These include either terminal differentiation (the long- lations of mature T and B cells (e.g., for review, see lived plasma cell) or metastable transcriptional repro- Busslinger 2004; Champhekar et al. 2015). Similarly, the gramming (germinal center and memory B cells). In this process of diversifying subsets of T cells after their activa- review, we focus principally on the regulation of differen- tion has been studied and reviewed intensively (Glimcher tiation and functional diversification of the “B2” subset. and Murphy 2000; Fang and Zhu 2017; Henning et al. An overview is combined with an account of more recent 2018). Mature B lymphocytes also have the potential to advances, including initial work on mechanisms that distribute their progeny among several distinct fates or eliminate DNA methylation and potential links between intermediate states after they have encountered a ligand intracellular metabolites and chromatin editing.
    [Show full text]
  • Pathogen Manipulation of B Cells: the Best Defence Is a Good Offence
    REVIEWS Pathogen manipulation of B cells: the best defence is a good offence Katharina Nothelfer1–3, Philippe J. Sansonetti1,2,4 and Armelle Phalipon1,2 Abstract | B cells have long been regarded as simple antibody production units, but are now becoming known as key players in both adaptive and innate immune responses. However, several bacteria, viruses and parasites have evolved the ability to manipulate B cell functions to modulate immune responses. Pathogens can affect B cells indirectly, by attacking innate immune cells and altering the cytokine environment, and can also target B cells directly, impairing B cell-mediated immune responses. In this Review, we provide a summary of recent advances in elucidating direct B cell–pathogen interactions and highlight how targeting this specific cell population benefits different pathogens. pattern recognition receptors 4–6 (FIG. 1) Immunoglobulin B cells are essential components of the adaptive immune general (PRRs) . The A large, Y‑shaped protein that system, and they were first defined and distinguished activation of several B cell clones (termed polyclonal is produced by B cells. from T cells almost 50 years ago1. Both B cells and T cells B cell activation) and their subsequent differentiation Immunoglobulins exist in a recognize pathogens with antigen-specific receptors, into short-lived plasma cells results in the production membrane-bound form as B cell receptors or are secreted but they differ in their developmental pathways and of low-specificity antibodies, which are generally asso- as antibodies. functions during infections. T cells differentiate in the ciated with the beneficial effects of an early weakening thymus and orchestrate immune responses as CD4+ of infections7.
    [Show full text]
  • Blys Inhibition Eliminates Primary B Cells but Leaves Natural and Acquired Humoral Immunity Intact
    BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact Jean L. Scholz*†, Jenni E. Crowley*†, Mary M. Tomayko‡, Natalie Steinel‡, Patrick J. O’Neill*, William J. Quinn III*, Radhika Goenka*, Juli P. Miller*, Yun Hee Cho§, Vatana Long§, Chris Ward§, Thi-Sau Migone§, Mark J. Shlomchik¶, and Michael P. Cancro*ʈ *Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6082; §Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850; and Departments of ¶Immunology and Laboratory Medicine and ‡Dermatology, Yale University School of Medicine, New Haven, CT 06520-8035 Communicated by Michael Potter, National Institutes of Health, Bethesda, MD, August 8, 2008 (received for review March 13, 2008) We have used an inhibiting antibody to determine whether pre- there has been no way to selectively manipulate BLyS availabil- immune versus antigen-experienced B cells differ in their requisites ity. Herein we ask whether these B cell subsets rely on BLyS by for BLyS, a cytokine that controls differentiation and survival. treating mice with an inhibiting anti-BLyS antibody. Whereas Whereas in vivo BLyS inhibition profoundly reduced naïve B cell this treatment eliminated preimmune B cells and primary anti- numbers and primary immune responses, it had a markedly smaller body responses, PerC B1 and memory B cell numbers were effect on memory B cells and long-lived plasma cells, as well as unaffected. Moreover, both secondary antibody responses and secondary immune responses. There was heterogeneity within the natural antibody production were normal. Finally, BLyS inhibi- memory pools, because IgM-bearing memory cells were sensitive tion did not affect established IgG antibody titers or LLPC to BLyS depletion whereas IgG-bearing memory cells were not, numbers.
    [Show full text]